Epigenetics in Non-tumor Immune-Mediated Skin Diseases

被引:0
|
作者
Alejandra Reolid
E. Muñoz-Aceituno
F. Abad-Santos
M. C. Ovejero-Benito
E. Daudén
机构
[1] Hospital Universitario de la Princesa,Dermatology Department
[2] Instituto de Investigación Sanitaria La Princesa (IIS-IP),Clinical Pharmacology Department
[3] Hospital Universitario de la Princesa,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd)
[4] Instituto Teófilo Hernando,undefined
[5] Universidad Autónoma de Madrid (UAM),undefined
[6] Instituto de Investigación Sanitaria la Princesa (IIS-IP),undefined
[7] Instituto de Salud Carlos III,undefined
来源
Molecular Diagnosis & Therapy | 2021年 / 25卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Epigenetics is the study of the mechanisms that regulate gene expression without modifying DNA sequences. Knowledge of and evidence about how epigenetics plays a causative role in the pathogenesis of many skin diseases is increasing. Since the epigenetic changes present in tumor diseases have been thoroughly reviewed, we believe that knowledge of the new epigenetic findings in non-tumor immune-mediated dermatological diseases should be of interest to the general dermatologist. Hence, the purpose of this review is to summarize the recent literature on epigenetics in most non-tumor dermatological pathologies, focusing on psoriasis. Hyper- and hypomethylation of DNA methyltransferases and methyl-DNA binding domain proteins are the most common and studied methylation mechanisms. The acetylation and methylation of histones H3 and H4 are the most frequent and well-characterized histone modifications and may be associated with disease severity parameters and serve as therapeutic response markers. Many specific microRNAs dysregulated in non-tumor dermatological disease have been reviewed. Deepening the study of how epigenetic mechanisms influence non-tumor immune-mediated dermatological diseases might help us better understand the role of interactions between the environment and the genome in the physiopathogenesis of these diseases.
引用
收藏
页码:137 / 161
页数:24
相关论文
共 50 条
  • [1] Epigenetics in Non-tumor Immune-Mediated Skin Diseases
    Reolid, Alejandra
    Munoz-Aceituno, E.
    Abad-Santos, F.
    Ovejero-Benito, M. C.
    Dauden, E.
    MOLECULAR DIAGNOSIS & THERAPY, 2021, 25 (02) : 137 - 161
  • [2] Epigenetics in Immune-Mediated Pulmonary Diseases
    Liu, Yu
    Li, Hui
    Xiao, Tao
    Lu, Qianjin
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2013, 45 (03) : 314 - 330
  • [3] Epigenetics in Immune-Mediated Pulmonary Diseases
    Yu Liu
    Hui Li
    Tao Xiao
    Qianjin Lu
    Clinical Reviews in Allergy & Immunology, 2013, 45 : 314 - 330
  • [4] IMMUNE-MEDIATED SKIN DISEASES
    ROSSER, EJ
    VETERINARY QUARTERLY, 1995, 17 : S37 - S38
  • [5] IMMUNE-MEDIATED EQUINE SKIN DISEASES
    MANNING, T
    SWEENEY, C
    COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN, 1986, 8 (12): : 979 - 986
  • [6] Immune-mediated skin diseases in the horse
    van Oldruitenborgh-Oosterbaan, MMS
    Goehring, LS
    PFERDEHEILKUNDE, 2001, 17 (04): : 346 - +
  • [7] Mechanisms of immune-mediated skin diseases: an overview
    Beissert, S
    Cavazzana, I
    Mascia, F
    Meroni, P
    Pastore, S
    Tessari, G
    Girolomoni, G
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (01) : S1 - S6
  • [8] Cyclosporin in less common immune-mediated skin diseases
    Ruzicka, T
    BRITISH JOURNAL OF DERMATOLOGY, 1996, 135 : 40 - 42
  • [9] Immune-Mediated Skin Diseases: Future Therapeutic Perspectives
    Alaibac, Mauro
    MEDICINA-LITHUANIA, 2023, 59 (10):
  • [10] Microbiota and Immune-Mediated Skin Diseases-An Overview
    Catinean, Adrian
    Neag, Maria Adriana
    Mitre, Andrei Otto
    Bocsan, Corina Ioana
    Buzoianu, Anca Dana
    MICROORGANISMS, 2019, 7 (09)